Clearing the Air: Evaluating Levalbuterol Use
Recommended Citation
de Jesus KS, Brunsman A, Globerman B, Wang N. Clearing the Air: Evaluating Levalbuterol Use. Am J Health Syst Pharm 2026; 83:S802.
Document Type
Conference Proceeding
Publication Date
3-6-2026
Publication Title
Am J Health Syst Pharm
Keywords
Pharmacology & Pharmacy
Abstract
Purpose: Specialty medications play an increasing role in managing complex, chronic conditions; however, despite their growing importance, many patients continue to face challenges in accessing these therapies due to high costs, complex insurance requirements, limited pharmacy networks, and administrative delays. Barriers often stem from insurance and PBM restrictions, which limit pharmacy choice and require patients to use company-affiliated specialty pharmacies. This project aims to assess whether patients using a pharmacist-led medication management clinic experience have a higher percentage of days covered, faster time to treatment, and greater satisfaction compared to those receiving usual care. Methods: This retrospective chart review consists of patients who are active patients with the pharmacist-led medication management clinic services between December 2023 and June 2025. Patients included are those who are age 18 years and older, have had at least one visit with the clinical pharmacist at the medication management clinic, have a formal diagnosis of asthma, chronic obstructive pulmonary disease, cystic fibrosis, or interstitial lung disease, and a referral to the medication management clinic from the pulmonologist for medication access assistance. Those excluded included referrals for medication access for cardiac conditions. Patients were further excluded if they did not have a documented prescription of days covered that requires two medication fills for an endpoint value, an MRN that does not match a patient in the pharmacy dispensing software, or a prescription number that does not match a patient in the specialty pharmacy patient monitoring system. Patient information collected includes their age, sex, primary pulmonary disease state, percentage of days covered, time to treat, specialty pharmacy utilized, office visit billing code, and patient satisfaction. There are currently 139 patients enrolled in the study.
Volume
83
First Page
S802
